Gå til indhold
Global sound
JACC Deep Dive

JACC Deep Dive

Revisiting the SUMMIT Trial | JACC Deep Dive

· 6 min.

Episodebeskrivelse

This JACC Deep Dive in our May 13 issue highlights new findings from the SUMMIT CKD study, showing that terzepatide improves symptoms, function, and weight in patients with HFpEF and obesity—regardless of kidney function. The analysis also underscores the importance of using both creatinine and cystatin C to better assess kidney health. Reviewers praised the study's methodological rigor and dual focus, while noting the need for larger, long-term trials to confirm renal outcomes.

Website: traffic.libsyn.com

Live, seneste time: 7.830 sange på 3.401 stationer i 130 lande

Opdag verden gennem radioen

Flere måder at opdage på (9)

Hørt noget godt? Gem det, eller åbn det direkte i Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
ROUGH RadioFortsæt med at lytte